Clinical TrialID 8230

The GALAXY-1 Project

NCT05986500

Healthy

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8230
Evidence Id
8230
Core Evidence Id
8230
Source Clinical Trial Id
8228
Herb2 Clinical Trial Id
HBCT008228
Nct Id
NCT05986500
Title
The GALAXY-1 Project
Status
Recruiting
Phase
Study Result
No
Study Condition
Healthy
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: PREVENTION
Intervention
OTHER: Galactose|OTHER: No intervention
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Intervention Purpose
Prevention
Gender
All
Age
Adult, Older_Adult
Enrollment
8
Outcome Measure
Galactose uptake in skeletal muscle, Skeletal muscle galactose uptake rate (μmol/min/g) measured by 2-(18)F-fluoro-2-deoxy-d-galactose (18F-FDGal), Measurements will be made on each of the two study days
Sponsor Collaborator
University of Aarhus
Funded By
OTHER
Location
Aarhus University Hospital, Aarhus N, Jutland, 8200, Denmark
Other Id
1-10-72-49-23
Start Date
2024-02-12
Primary Completion Date
2024-11-01
Completion Date
2025-05-31
First Posted
2023-08-14
Results First Posted
Last Update Posted
2024-04-23
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05986500
Title Cn
Title En
The GALAXY-1 Project
Bilingual Status
semi_complete